Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lublin

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1994
Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1M W Nickells, J I Alvarez, D M Lublin, et al.
The Journal of Experimental Medicine|May 1, 1985
Human genes for three complement components that regulate the activation of C3 are tightly linkedS Rodriguez de Cordoba, D M Lublin, P Rubinstein, et al.
The Journal of Experimental Medicine|December 1, 1993
Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interactionB Nowicki, A Hart, K E Coyne, et al.
Transfusion|August 21, 2004
Transfusion medicine service policies for recombinant factor VIIa administrationLawrence Tim Goodnough, Douglas M Lublin, Lini Zhang, et al.
The Journal of Biological Chemistry|June 2, 1995
Distinct tyrosine kinase activation and Triton X-100 insolubility upon Fc gamma RII or Fc gamma RIIIB ligation in human polymorphonuclear leukocytes. Implications for immune complex activation of the respiratory burstM J Zhou, D M Lublin, D C Link, et al.
Clinical and Experimental Immunology|June 1, 1987
The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosusS Van Dyne, V M Holers, D M Lublin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factorD M Lublin, J Krsek-Staples, M K Pangburn, et al.
Journal of Clinical Apheresis|October 20, 2004
Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolationA Alex Hofling, Mark S Sands, Douglas M Lublin, et al.
The Journal of Biological Chemistry|August 30, 2003
Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1Youchun Zeng, Nengbing Tao, Koong-Nah Chung, et al.
Transfusion|December 25, 2003
Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?Pampee P Young, Alison Uzieblo, Elbert Trulock, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1994
Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1M W Nickells, J I Alvarez, D M Lublin, et al.
The Journal of Experimental Medicine|May 1, 1985
Human genes for three complement components that regulate the activation of C3 are tightly linkedS Rodriguez de Cordoba, D M Lublin, P Rubinstein, et al.
The Journal of Experimental Medicine|December 1, 1993
Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interactionB Nowicki, A Hart, K E Coyne, et al.
Transfusion|August 21, 2004
Transfusion medicine service policies for recombinant factor VIIa administrationLawrence Tim Goodnough, Douglas M Lublin, Lini Zhang, et al.
The Journal of Biological Chemistry|June 2, 1995
Distinct tyrosine kinase activation and Triton X-100 insolubility upon Fc gamma RII or Fc gamma RIIIB ligation in human polymorphonuclear leukocytes. Implications for immune complex activation of the respiratory burstM J Zhou, D M Lublin, D C Link, et al.
Clinical and Experimental Immunology|June 1, 1987
The polymorphism of the C3b/C4b receptor in the normal population and in patients with systemic lupus erythematosusS Van Dyne, V M Holers, D M Lublin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1986
Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factorD M Lublin, J Krsek-Staples, M K Pangburn, et al.
Journal of Clinical Apheresis|October 20, 2004
Collection of a mobilized peripheral blood apheresis product from a patient with mucopolysaccharidosis type VII and subsequent CD34+ cell isolationA Alex Hofling, Mark S Sands, Douglas M Lublin, et al.
The Journal of Biological Chemistry|August 30, 2003
Endocytosis of oxidized low density lipoprotein through scavenger receptor CD36 utilizes a lipid raft pathway that does not require caveolin-1Youchun Zeng, Nengbing Tao, Koong-Nah Chung, et al.
Transfusion|December 25, 2003
Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?Pampee P Young, Alison Uzieblo, Elbert Trulock, et al.
Pageof 9